Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 10 | 2023 | 2291 | 1.050 |
Why?
|
| Genomics | 7 | 2023 | 2738 | 1.020 |
Why?
|
| Sequence Analysis, DNA | 8 | 2023 | 2483 | 0.910 |
Why?
|
| Benchmarking | 2 | 2023 | 273 | 0.850 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 77 | 0.680 |
Why?
|
| Genome, Human | 9 | 2023 | 1869 | 0.660 |
Why?
|
| Software | 4 | 2022 | 1321 | 0.660 |
Why?
|
| Genetic Variation | 3 | 2021 | 2086 | 0.580 |
Why?
|
| Nanopores | 3 | 2022 | 16 | 0.470 |
Why?
|
| Haplotypes | 4 | 2022 | 856 | 0.410 |
Why?
|
| DNA Methylation | 1 | 2021 | 2669 | 0.400 |
Why?
|
| Genome | 3 | 2023 | 672 | 0.260 |
Why?
|
| Chromosomes, Mammalian | 1 | 2022 | 59 | 0.210 |
Why?
|
| Mesocricetus | 1 | 2022 | 114 | 0.210 |
Why?
|
| Cryptosporidium | 1 | 2022 | 47 | 0.210 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 82 | 0.200 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 60 | 0.200 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 86 | 0.200 |
Why?
|
| Genome, Viral | 1 | 2021 | 155 | 0.190 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 192 | 0.180 |
Why?
|
| Genome, Mitochondrial | 1 | 2019 | 37 | 0.180 |
Why?
|
| DNA, Circular | 1 | 2019 | 34 | 0.180 |
Why?
|
| Chromosomes, Human | 1 | 2020 | 295 | 0.170 |
Why?
|
| Exome | 1 | 2023 | 1239 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 413 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 1217 | 0.150 |
Why?
|
| Computational Biology | 1 | 2023 | 1271 | 0.150 |
Why?
|
| Abnormalities, Multiple | 1 | 2022 | 998 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2023 | 708 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2023 | 1589 | 0.130 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1032 | 0.130 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 2265 | 0.120 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 980 | 0.120 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 1105 | 0.120 |
Why?
|
| Humans | 18 | 2023 | 261506 | 0.100 |
Why?
|
| Whole Genome Sequencing | 2 | 2023 | 338 | 0.090 |
Why?
|
| Virus Integration | 1 | 2023 | 76 | 0.060 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 37 | 0.060 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 49 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 107 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2021 | 78 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 214 | 0.050 |
Why?
|
| Clonal Evolution | 1 | 2023 | 253 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2020 | 73 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 200 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2023 | 351 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2023 | 624 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 558 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2023 | 783 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 4549 | 0.040 |
Why?
|
| Animals | 2 | 2022 | 59536 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 314 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 311 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 1020 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 984 | 0.040 |
Why?
|
| Genotype | 1 | 2023 | 4109 | 0.030 |
Why?
|
| DNA | 1 | 2021 | 2693 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 4917 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 6295 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 3890 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 4821 | 0.020 |
Why?
|